RecruitingNCT07167563

Real-world Lithium Intake

Real-world Lithium Intake Measured by a Pillbox: A Clinical Study to Test Real-world Compliance With Lithium Treatment

Sponsor

University of Aarhus

Enrollment

50 participants

Start Date

Jul 5, 2025

Study Type

OBSERVATIONAL

Conditions

Bipolar Disorder (BD)

Summary

The aim of the present study is to study compliance with lithium therapy and patterns of lithium intake among a representative group of patients with bipolar disorder in a real-world clinical setting. This will be studied via a pill box that registers the daily time when the participant took the lithium tablet out of the pill box, representing a proxy for the actual lithium intake. Participants will receive a weekly phone call asking for several aspects of lithium intake.

Eligibility

Min Age: 18 Years

Inclusion Criteria5

Age ≥18 years
Diagnosed with bipolar disorder (ICD-10: F30-31)
Followed at the bipolar disorder outpatient clinic at AUHP
Treated with lithium (ATC-code: N05AN01)
Able to give informed oral and written consent.

Exclusion Criteria2

Any coercive measure in the study period including patients in forensic psychiatry.
In a clinical condition where the treating clinician evaluates that the patient is not able to attend the research study.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERLithium (LI) based on clinical indication

Participants have for 4 weeks a pill box registering the time for lithium intake. Weekly phone calls will assess whether patients can remember the time for lithium intake.